The CEIBS China Healthcare Innovation Platform Competition Selects Milu Labs as a Finalist
NEW YORK, June 11, 2020 — Milu Labs, which seeks to produce the most sophisticated diagnostics in women’s health across Asia, is pleased to announce that it has been selected…
Read More
Milu Labs and Thermo Fisher Scientific Announce Collaboration MOU to Advance the expansion of “Women’s Health Products” in the Asia market
NEW YORK, Oct. 23, 2019 /PRNewswire/ -- Thermo Fisher Scientific, the world leader in serving science, and Milu Labs., whose mission is to become the leading diagnostic and analysis company focused on cutting edge…
Read More
Milu Labs Secures Seed Financing From Top Healthcare Investor in Asia
NEW YORK, NY and SEOUL, SOUTH KOREA – March 7, 2019 – Milu Labs, an innovative medical diagnostics company, announced today the completion of its first institutional financing. The funding…
Read More
NX Prenatal and Milu Labs Announce Strategic Collaboration to Commercialize Exosome-Based Preterm Birth Risk Test in Asia
LOUISVILLE, Ky. and NEW YORK, Jan. 16, 2019 /PRNewswire/ -- NX Prenatal Inc., a privately held women's healthcare molecular diagnostic company, announced today that it has entered into a strategic collaboration with Milu Labs, whose…
Read More
English 
Chinese